SPECIMEN — ILLUSTRATIVE FORMAT. This certificate shows the COA layout for this compound. Lot number, dates, and measured results (shown as “____”) are completed on the certificate issued with each shipped lot.
Product Identification
| Product | AOD9604 (HXR-AOD9604) |
|---|
| Full name | AOD9604 (modified human growth hormone fragment 176-191) |
|---|
| CAS No. | 221231-10-3 |
|---|
| Molecular formula | C₇₈H₁₂₃N₂₃O₂₃S₂ |
|---|
| Molecular weight | 1815.1 g/mol |
|---|
| Appearance | White lyophilized powder |
|---|
| Lot No. | ____ |
|---|
| Manufacture date | ____ |
|---|
| Re-test date | ____ |
|---|
| Quantity | 5 mg |
|---|
Analytical Results
| Test | Method | Specification | Result |
|---|
| Purity | RP-HPLC | ≥98% (HPLC) | ____ |
| Identity | ESI-MS | Consistent with MW | ____ |
| Appearance | Visual | White powder | ____ |
| Solubility | Visual | Soluble in water / AcOH | ____ |
| Water content | Karl Fischer | ≤ spec | ____ |
| Counterion (acetate / TFA) | HPLC | Report | ____ |
SequenceTyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (16-residue HGH(176-191) fragment; N-terminal Tyr substituted for the native Phe; intramolecular Cys7–Cys14 disulfide bridge)
Storage & Handling
Store at −20°C, desiccated, protect from light. Minimize freeze–thaw cycles. Reconstitute under aseptic laboratory conditions.
Reviewed / Approved by ____________________ (QC)
Date ____________________
RESEARCH USE ONLY
Not for human or veterinary use, food, drug, or therapeutic application.
Helix Reagents LLC · helixbiosci.com ·
HXR-AOD9604
This certificate is valid only for the lot identified above.